Table 2. Comparison of sulfadiazine (SDZ) and sulfamonomethoxine (SMM) oral pharmacokinetics in Holstein cows (n=4) after their intravenous (5 mg/kg BW) and oral administration (10 mg/kg BW).
| Parameters | Units | SDZ | SMM |
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| ka | hr−1 | 0.158 ± 0.029 | 0.179 ± 0.023* |
| t1/2ka | hr | 4.51 ± 0.82 | 3.91 ± 0.51* |
| kel | hr−1 | 0.262 ± 0.027 | 0.433 ± 0.058* |
| t1/2kel | hr | 2.66 ± 0.25 | 1.62 ± 0.24* |
| Cmax | µg/mL | 7.01 ± 0.50 | 4.29 ± 0.32* |
| Tmax | hr | 5.00 ± 1.15 | 2.75 ± 0.96* |
| F | % | 85.7 ± 2.7 | 89.5 ± 7.3 |
| MAT | hr | 5.92 ± 1.11 | 5.24 ± 0.69* |
| MRTi.v. | hr | 3.69 ± 0.32 | 2.21 ± 0.31* |
| MRTp.o. | hr | 9.61 ± 1.27 | 7.45 ± 0.66* |
| AUCi.v. | µg/hr/mL | 52.0 ± 6.5 | 25.1 ± 3.0* |
| AUCp.o. | µg/hr/mL | 98.5 ± 13.1 | 45.6 ± 6.0* |
| CLtot | L/hr/kg | 0.0973 ± 0.0118 | 0.202 ± 0.023* |
| Vdss | L/kg | 0.357 ± 0.027 | 0.445 ± 0.081 |
ka=primary absorption rate constant; t1/2ka=absorption half-life; kel=primary elimination rate constant; t1/2kel=elimination half-life; Cmax=maximum blood concentration; Tmax=time to maximum plasma concentration; F=oral bioavailability percentage; MAT=Mean absorption time; MRTi.v.=average residence time during intravenous administration; MRTp.o.=average residence time during oral administration; AUCi.v.=area under the plasma concentration-time curve after intravenous injection; AUCp.o.=area under the plasma concentration-time curve after oral administration; CLtot=total body clearance; Vdss=distribution volume at steady state.